TAP Pharmaceutical Products was formed in 1977 as a joint venture between the two global pharmaceutical companies, Abbott Laboratories and Takeda Pharmaceutical Co. The company markets Prevacid (lansoprazole) and Lupron Depot (leuprolide acetate for depot suspension), both leaders in their classes.